Clinical Trial Detail

NCT ID NCT02978404
Title Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre hospitalier de l'Université de Montréal (CHUM)
Indications

clear cell renal cell carcinoma

lung non-small cell carcinoma

Therapies

Nivolumab

Age Groups: senior adult

No variant requirements are available.